Isto Biologics - Company Review
SummaryIsto Biologics - Company Review
Summary
Isto Biologics (Isto), formerly ISTO Technologies Inc, is an orthobiologics company which manufactures and develops products to treat orthopedic and spine disorders. The company offers solutions in cell therapy and rapid bone healing. Its product portfolio includes InQu, a bone graft extender and substitute which is a biosynthetic bone graft; Influx, a trabecular bone graft; Magellan, an autologous platelet separator; and CellPoint, a concentrated bone marrow aspirate system. Isto’s patented biosynthetic platform, which is utilized in the InQu bone graft, is composed of synthetic poly (lactide-co-glycolide) (PLGA) combined with hyaluronic acid (HyA). Isto is also evaluating its InQu bone graft extender in spinal fusion procedures. Isto is headquartered in Saint Louis, Missouri, the US.
This comprehensive company report of Isto Biologics provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.